JP2017537605A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017537605A5 JP2017537605A5 JP2017517300A JP2017517300A JP2017537605A5 JP 2017537605 A5 JP2017537605 A5 JP 2017537605A5 JP 2017517300 A JP2017517300 A JP 2017517300A JP 2017517300 A JP2017517300 A JP 2017517300A JP 2017537605 A5 JP2017537605 A5 JP 2017537605A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- virus
- amino acid
- biologically active
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462058945P | 2014-10-02 | 2014-10-02 | |
| US62/058,945 | 2014-10-02 | ||
| PCT/US2015/053393 WO2016054312A1 (en) | 2014-10-02 | 2015-10-01 | Influenza a virus variants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017537605A JP2017537605A (ja) | 2017-12-21 |
| JP2017537605A5 true JP2017537605A5 (enExample) | 2018-11-08 |
| JP6953307B2 JP6953307B2 (ja) | 2021-10-27 |
Family
ID=54293399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017517300A Expired - Fee Related JP6953307B2 (ja) | 2014-10-02 | 2015-10-01 | インフルエンザａ型ウイルスバリアント |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10801077B2 (enExample) |
| EP (1) | EP3201221A1 (enExample) |
| JP (1) | JP6953307B2 (enExample) |
| CN (1) | CN107002052B (enExample) |
| CA (1) | CA2963076A1 (enExample) |
| MA (1) | MA40773A (enExample) |
| WO (1) | WO2016054312A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010262905B2 (en) | 2009-06-17 | 2015-04-16 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| EP3068782B1 (en) | 2013-11-13 | 2018-05-23 | Vertex Pharmaceuticals Incorporated | Methods of preparing inhibitors of influenza viruses replication |
| ES2741444T3 (es) | 2013-11-13 | 2020-02-11 | Vertex Pharma | Inhibidores de la replicación de virus de la gripe |
| MA40772A (fr) * | 2014-10-02 | 2017-08-08 | Vertex Pharma | Variants du virus de la grippe a |
| WO2016183120A1 (en) | 2015-05-13 | 2016-11-17 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| WO2016183116A1 (en) | 2015-05-13 | 2016-11-17 | Vertex Pharmaceuticals Incorporated | Methods of preparing inhibitors of influenza viruses replication |
| CN106929482A (zh) * | 2015-12-31 | 2017-07-07 | 北京大学 | 定点突变的流感病毒、其活疫苗及其制备方法和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843701A (en) | 1990-08-02 | 1998-12-01 | Nexstar Pharmaceticals, Inc. | Systematic polypeptide evolution by reverse translation |
| KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
| DE69739163D1 (de) | 1996-10-17 | 2009-01-22 | Mitsubishi Chem Corp | Molekül, welches Genotyp und Phänotyp zusammenführt und dessen Anwendungen |
| PT971946E (pt) | 1997-01-21 | 2006-11-30 | Gen Hospital Corp | Selecção de proteínas utilizando fusões arn-proteína |
| DE60137345D1 (de) * | 2000-04-28 | 2009-02-26 | St Jude Childrens Res Hospital | Dna-transfektionssystem zur erzeugung von infektiösen negativsträngigen rna virus |
| CA2456292A1 (en) | 2001-08-14 | 2003-02-27 | Toyama Chemical Co., Ltd. | Novel virus growth inhibitor and/or virucidal method, and novel pyrazine nucleotide or pirazine nucleoside analog |
| WO2005095400A1 (en) | 2004-03-30 | 2005-10-13 | Vertex Pharmaceuticals Incorporated | Azaindoles useful as inhibitors of jak and other protein kinases |
| WO2006050076A1 (en) | 2004-10-29 | 2006-05-11 | Janssen Pharmaceutica, N.V. | Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders |
| FI20060200A0 (fi) | 2005-04-20 | 2006-02-27 | Glykos Finland Oy | Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi |
| PL1896470T3 (pl) | 2005-05-16 | 2011-03-31 | Irm Llc | Pochodne pirolopirydynowe jako inhibitory kinazy białkowej |
| KR20080047355A (ko) * | 2005-07-06 | 2008-05-28 | 바이오칩 이노베이션즈 피티와이 리미티드 | 표적 핵산 서열 분석 방법 및 키트 |
| KR100708593B1 (ko) | 2006-03-23 | 2007-04-18 | 주식회사 고려비엔피 | 발육란 생산성이 우수한 저병원성 ｈ９ｎ２ 아형 조류인플루엔자 바이러스 |
| WO2009125395A1 (en) * | 2008-04-09 | 2009-10-15 | Technion Research & Development Foundation Ltd. | Anti influenza antibodies and uses thereof |
| AU2010262905B2 (en) | 2009-06-17 | 2015-04-16 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| UA118010C2 (uk) * | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| MA40772A (fr) | 2014-10-02 | 2017-08-08 | Vertex Pharma | Variants du virus de la grippe a |
| WO2016183120A1 (en) | 2015-05-13 | 2016-11-17 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
-
2015
- 2015-09-30 MA MA040773A patent/MA40773A/fr unknown
- 2015-10-01 JP JP2017517300A patent/JP6953307B2/ja not_active Expired - Fee Related
- 2015-10-01 CA CA2963076A patent/CA2963076A1/en not_active Abandoned
- 2015-10-01 CN CN201580063468.8A patent/CN107002052B/zh not_active Expired - Fee Related
- 2015-10-01 WO PCT/US2015/053393 patent/WO2016054312A1/en not_active Ceased
- 2015-10-01 EP EP15779136.9A patent/EP3201221A1/en not_active Withdrawn
-
2017
- 2017-03-31 US US15/475,326 patent/US10801077B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017537605A5 (enExample) | ||
| JP2017536804A5 (enExample) | ||
| Álvarez-Buylla et al. | Identification of Acinetobacter species: is Bruker biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques? | |
| Okomo‐Adhiambo et al. | Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors | |
| US20140005070A1 (en) | Markers associated with cyclin-dependent kinase inhibitors | |
| RU2017114675A (ru) | Варианты вируса гриппа a | |
| Jagielski et al. | Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates | |
| EP2630239B1 (en) | Kit for detecting bovine leukemia virus (blv), and use thereof | |
| Zhan et al. | Evolution of methicillin-resistant Staphylococcus aureus: Evidence of positive selection in a penicillin-binding protein (PBP) 2a coding gene mecA | |
| Cotroneo et al. | Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants | |
| WO2016042114A1 (en) | Cxcl14 as a biomarker of hedgehog pathway activity for the diagnosis, prognosis and treatment of idiopathic pulmonary fibrosis | |
| CN102559898A (zh) | 检测人α防御素1/3基因拷贝数的试剂盒及方法 | |
| WO2015172734A1 (zh) | 结核分枝杆菌四种二线药物耐药基因特异片段组合及其应用 | |
| Sun et al. | Molecular typing of epizootic hemorrhagic disease virus serotypes by one-step multiplex RT-PCR | |
| Fidler et al. | Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis | |
| KR20230117152A (ko) | 코로나바이러스 감염 발생 위험이 증가한 대상체의 식별 및 이의 치료 방법 | |
| CN103540676B (zh) | 一种检测线粒体基因1555位a-g与1494位c-t突变的试剂盒 | |
| JP7084034B2 (ja) | 神経芽腫の微小残存病変を評価するために用いられる試薬、およびそれを用いた生体試料の分析方法 | |
| JPWO2020032228A5 (enExample) | ||
| Wei et al. | Genetic diversity and transmission pattern of multidrug-resistant tuberculosis based on whole-genome sequencing in Wuhan, China | |
| US10519502B2 (en) | Mitochondrial disease genetic diagnostics | |
| CN111315897B (zh) | 用于黑素瘤检测的方法 | |
| CN102925555B (zh) | 定性检测人类braf v600e基因突变的测序引物组及其试剂盒 | |
| Doumayrou et al. | Mapping genetic determinants of viral traits with FST and quantitative trait locus (QTL) approaches | |
| CN103555837B (zh) | 人ror2基因突变及其用途 |